Raymond, Perrine
Klein, Marc
Cuny, Thomas
Klein, Olivier
Salleron, Julia
Bernier-Chastagner, Valérie
Article History
Received: 16 February 2021
Accepted: 18 November 2021
First Online: 18 December 2021
Declarations
:
: The study has been declared to the French National Commission on Information Technology and Liberties (CNIL) on April 122,019 and has been registered by the Data Protection Officer of the Cancer Institute of Lorraine French Region (Number 165). According to the CNIL MR004 compliance declaration, all patients are informed of the potential retrospective use of their clinical data for research purpose and of their right to refuse. Individual written consent was consequently waived in light of those elements. The study was approved by the scientific and ethical committee of the Institut de Cancérologie de Lorraine, Nancy, France.
: Not applicable.
: All authors declare that they have no competing interests.